Establishing the Individual Immune Identity Card of Scleroderma Patients

Establishing the Individual Immune Identity Card of Scleroderma Patients

At the request of several provincial scleroderma (Scl) associations, I am pleased to provide an overview of recent research carried out under the University of Montreal Scleroderma Research Chair.

For the past several years, an advanced program of translational research on Scl is in progress in Montreal at the Research Center of the Centre Hospitalier de l’Université de Montréal (CHUM). This program results from a close collaboration between the Laboratory for Immunoregulation, directed by Marika Sarfati, MD, PhD, an immunologist and basic scientist, and the Laboratory for Research on Autoimmunity, directed by the undersigned, a rheumatologist and clinician researcher specialized in the care of Scl patients.

To read the full report in English press here.

To read the full report in French press here.

Thank you for your interest in donating to Scleroderma Atlantic. With donations like yours, we're able to make a difference in the community.

Our donations are currently processed through Scleroderma Canada. You will be redirected to their page by clicking below. Please be sure to select #4 on the drop down menu to ensure the funds are allocated to the Atlantic region!